Realty Income Corp. (NYSE:O)

CAPS Rating: 3 out of 5

An equity real estate investment trust whose primary business objective is to generate dependable monthly cash distributions from a consistent and predictable level of funds from operations per share.

Results 1 - 20 of 126 : 1 2 3 4 5 6 7 Next »

Recs

0
Member Avatar moonlightsail (< 20) Submitted: 7/21/2014 11:09:26 AM : Outperform Start Price: $45.21 O Score: -4.13

A real estate REIT with a growing portfolio.

Recs

0
Member Avatar afewgoodstocks11 (27.73) Submitted: 6/6/2014 11:16:39 AM : Outperform Start Price: $39.22 O Score: -4.75

Div. (Yield) $2.19 (5.0%)

Recs

0
Member Avatar SnowBawl (< 20) Submitted: 5/6/2014 8:05:45 AM : Outperform Start Price: $42.93 O Score: -3.59

Sizemore retirement reit with increasing dividends.

Recs

0
Member Avatar silvertrader1974 (27.47) Submitted: 4/26/2014 1:42:21 PM : Outperform Start Price: $42.27 O Score: -2.54

solid reit, best off breed

Recs

0
Member Avatar afewgoodstocks14 (34.91) Submitted: 4/10/2014 4:25:12 PM : Outperform Start Price: $39.96 O Score: -0.62

Div. (Yield) $2.19 (5.2%)

Recs

0
Member Avatar raypinero123 (42.81) Submitted: 1/26/2014 4:47:05 PM : Outperform Start Price: $38.48 O Score: +2.89

Gotta love a steady cash flow/Dividend

Recs

1
Member Avatar BobbieBunch (36.66) Submitted: 1/9/2014 12:04:26 PM : Outperform Start Price: $36.45 O Score: +11.69

Fear put this REIT on sale.

Recs

0
Member Avatar bassnman45 (33.41) Submitted: 1/7/2014 12:17:43 AM : Outperform Start Price: $41.33 O Score: -21.87

Buy, hold long term, maybe forever and monitor

Recs

0
Member Avatar LorenzoGrange (< 20) Submitted: 12/26/2013 7:30:06 PM : Outperform Start Price: $36.79 O Score: +11.06

People are hungry for yield

Recs

0
Member Avatar BaseBawl (23.40) Submitted: 12/13/2013 11:19:23 AM : Outperform Start Price: $36.54 O Score: +8.25

Monthly dividend.

Recs

0
Member Avatar john603 (55.30) Submitted: 11/29/2013 2:16:11 PM : Outperform Start Price: $36.80 O Score: +9.26

taking a chance on this. I think they will not DECREASE the monthly dividend. It is down on disappointment that the big purchase did not jump the earnings. BUT the cash flow increase is amazing.

Recs

0
Member Avatar WCA3 (< 20) Submitted: 11/24/2013 12:40:34 AM : Outperform Start Price: $37.45 O Score: +7.26

Solid company, solid dividends and 52 week low. Great time to get in.

Recs

0
Member Avatar HarryCarysGhost (99.70) Submitted: 11/23/2013 3:48:55 PM : Outperform Start Price: $37.45 O Score: +7.26

This looks cheap to me.

Recs

1
Member Avatar MrPipes (74.35) Submitted: 11/22/2013 11:35:07 AM : Outperform Start Price: $37.18 O Score: +7.61

Currently running At 52 week lows, the is a solid company in the real estate sector. A good time to get in before folks realize it is overly sold.

Recs

0
Member Avatar rms4096 (< 20) Submitted: 11/13/2013 4:11:12 PM : Outperform Start Price: $37.34 O Score: +5.73

Good management with loyal investors. Carl Icahn couldn't even take down this stock.

Recs

0
Member Avatar awallejr (83.91) Submitted: 10/14/2013 3:11:59 PM : Outperform Start Price: $38.99 O Score: -3.78

An oversold solid yield play.

Recs

0
Member Avatar AUFool (57.91) Submitted: 9/27/2013 7:55:36 AM : Outperform Start Price: $39.15 O Score: -5.72

Conservative management, focus on downside protection for the next economic downturn, predictable income.

Recs

0
Member Avatar yatharthg (< 20) Submitted: 9/20/2013 1:38:15 AM : Outperform Start Price: $38.69 O Score: -2.04

This is a great buy and the monthly income keeps adding over. Own it for over 3 years - it's really starting to add up.

Recs

0
Member Avatar Marlonito9 (< 20) Submitted: 9/19/2013 7:43:36 PM : Outperform Start Price: $38.47 O Score: -1.55

This equity real estate business group is doing great against the S&P 500 last year specially in May. This can do same next years or so.

Recs

0
Member Avatar 1elk (29.95) Submitted: 9/9/2013 1:41:57 PM : Outperform Start Price: $37.99 O Score: -3.41

You have to like the monthly dividends!

Featured Broker Partners


Advertisement